Two-drug phase I trial shows promise in treating late-stage ovarian cancer
Saturday, June 12, 2010 - 21:30
in Health & Medicine
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer, according to researchers.